Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

681 - 690 of 2157 results found

Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210)

Date
Saturday, October 28, 2023 - 4:00 AM
Description
CONCLUSIONS: Adoptive cell therapy with off-the-shelf CD45RA^(-) memory T cells containing SAR-CoV-2-specific T cells is safe, effective and accelerates lymphocyte recovery of patients with COVID-19 pneumonia and/or lymphopenia.

Re-Emergence of HMPV in Gwangju, South Korea, after the COVID-19 Pandemic

Date
Friday, October 27, 2023 - 4:00 AM
Description
The non-pharmaceutical interventions implemented to prevent the spread of COVID-19 have affected the epidemiology of other respiratory viruses. In South Korea, Human metapneumovirus (HMPV) typically occurs from winter to the following spring; however

Routine Vaccination Coverage - Worldwide, 2022

Date
Thursday, October 26, 2023 - 4:00 AM
Description
In 2020, the World Health Assembly endorsed the Immunization Agenda 2030 (IA2030), the 2021-2030 global strategy that envisions a world where everyone, everywhere, at every age, fully benefits from vaccines. This report reviews trends in World Health

Research progress in vaccines of SARS-CoV-2

Date
Thursday, October 26, 2023 - 4:00 AM
Description
Since the outbreak of corona virus disease 2019 (COVID-19), viral strains have mutated and evolved. Vaccine research is the most direct and effective way to control COVID-19. According to different production mechanisms, severe acute respiratory